Lidotran

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Lidotran
Generic name: LIDOCAINE HYDROCHLORIDE
Manufacturer: PureTek Corporation
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: cf715e54-c413-1e8f-e053-2995a90a076d
SPL ID: cf715e54-c411-1e8f-e053-2995a90a076d
Version: 1
Effective date: 2022-09-19
Source export date: 2026-09-28
Source partition: 9
Source file: https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/6784607726c827491ceaeab30d843632e0660ee8008c535197be5ed9e1e52201/drug-label-0009-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:03:19

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Lidotran	openfda.brand_name
generic name		LIDOCAINE HYDROCHLORIDE	openfda.generic_name
manufacturer name		PureTek Corporation	openfda.manufacturer_name
ndc	package	59088-483-07	openfda.package_ndc
ndc	product	59088-483	openfda.product_ndc
ndc11	package	59088048307	derived:openfda.package_ndc
rxcui		1723991	openfda.rxcui
rxcui		2611978	openfda.rxcui
spl id		cf715e54-c411-1e8f-e053-2995a90a076d	id
spl set id		cf715e54-c413-1e8f-e053-2995a90a076d	set_id
unii		V13007Z41A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS For external use only. Not for ophthalmic use.

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.